Previous 10 | Next 10 |
2024-01-16 11:49:56 ET More on iShares Russell 1000 Growth ETF: IWF: Price Isn't Everything; Favor Growth Over Value Citi’s 30 stocks for its 2024 top themes Top overweight stocks with high growth and low volume - MS Seeking Alpha’s Quant Rating...
2024-01-09 14:52:04 ET Shares of contract manufacturer Catalent ( NYSE: CTLT ) traded higher on Tuesday to reach the highest level in more than four months after its CEO, Alessandro Maselli, highlighted the company’s production capacity related to GLP-1 class of weight loss d...
2024-01-07 05:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that members of its executive leadership team will participate at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, at 5:15 p.m. ET. ...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that its wholly owned subsidiary, Catalent Pharma Solutions, Inc., as borrower, and certain other wholly owned subsidiaries of Catalent, entered into an amen...
2023-12-15 08:57:07 ET More on Catalent Catalent: Debt Remains An Overhang Catalent trades higher after quarterly beat For further details see: Catalent regains compliance with NYSE's listing standards
2023-12-13 11:14:23 ET Summary Today, we revisit drug manufacturer Catalent, Inc., which has expanded its board membership at the behest of activist investor Elliott Management. Analysts remain skeptical about Catalent's turnaround story, but the company has made progress and has ...
2023-11-30 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-17 16:16:14 ET More on Lonza Group AG Lonza: The Day Has Come, And We Lower Our Expectation Lonza Group: Downside Scenario Already Priced In Historical earnings data for Lonza Group AG Dividend scorecard for Lonza Group AG Financial informatio...
2023-11-16 12:06:34 ET More on Catalent Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent, Inc. 2024 Q1 - Results - Earnings Call Presentation Catalent Remains Overvalued Catalent trades higher after quarterly beat Paul Singer's Elliott ...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...